Brazilian Senator Soraya Thronicke Opposes Anvisa's E-Cigarette Ban

Regulations by 2FIRSTS.ai
Apr.29.2024
Brazilian Senator Soraya Thronicke Opposes Anvisa's E-Cigarette Ban
Brazilian Senator Soraya Thronicke opposes Anvisa's decision to maintain the ban on e-cigarettes, criticizing its impact on public health.

According to Topmidia News on April 28th, Brazilian Senator Soraya Thronicke spoke out against the decision made by Brazil's National Health Surveillance Agency (Anvisa) to maintain the ban on e-cigarettes. The Senator had previously met with major players in the global tobacco industry and advocated for regulation of such products.

 

Brazilian Senator Soraya Thronicke Opposes Anvisa's E-Cigarette Ban

 

Suraya emphasized that the ban will only benefit organized crime and goes against the principles of most developed countries.

 

Anvisa has brought the worst aspects of nicotine consumption to the people of Brazil.

 

The lawmaker expressed confusion over Anvisa's decision to maintain the ban on e-cigarettes. She tweeted, "We find this unanimous decision strange, at Anvisa, all resolutions are unanimous, this is too coincidental." She later posted another tweet stating, "Perhaps a public investigation can clarify these issues," sparking public skepticism about the fairness of Anvisa's decision-making. Currently, the lawmaker is being referred to as the "Tobacco Queen" by Brazilian media.

 

According to Anvisa, the injunction being maintained includes:

 

The ban on manufacturing, importing, selling, distributing, storing, transporting, and promoting all e-cigarette devices, including accessories, parts, and additives, will continue. Importing products into the country in any form, including personal luggage, remains prohibited. The approved regulations do not prohibit individual use.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

PMI Q1 Revenue Hits $9.3B, ZYN US Shipments Jump 53% to 200M Cans
PMI Q1 Revenue Hits $9.3B, ZYN US Shipments Jump 53% to 200M Cans
In Q1 2025, Philip Morris International reported net revenue of $9.301 billion, up 5.8% year-over-year, with operating income rising 16.4% to $3.544 billion. Smoke-free products accounted for 42% of net revenue and 44% of gross profit. Total shipment volume grew 14.4%, with heated tobacco products like IQOS reaching record market shares in Japan and Europe. ZYN nicotine pouch shipments in the U.S. surged 53% year-over-year.
Apr.24 by 2FIRSTS.ai
Executives of Flava, Flare, and Denkat Brands Sued by Philippines' BIR for Alleged Tax Evasion, Involving $160 Million
Executives of Flava, Flare, and Denkat Brands Sued by Philippines' BIR for Alleged Tax Evasion, Involving $160 Million
On April 29, the Philippines' BIR sued executives of Flava, Flare, and Denkat brands for failing to register and evading $160 million in taxes. The BIR accused them of violating the National Internal Revenue Code and pledged to pursue illegal e-cigarette operators and promoters.
Apr.29 by 2FIRSTS.ai
Notice on the Supervision and Inspection Plan of Shenzhen e-cigarette Products in the First Half of 2025
Notice on the Supervision and Inspection Plan of Shenzhen e-cigarette Products in the First Half of 2025
Shenzhen Tobacco Monopoly Bureau issues notice on quality supervision of e-cigarette products in the first half of 2025.
Apr.21 by 2FIRSTS.ai
Product|WASPE 60000 Launches in U.S. with 3-in-1 Design and 60,000 Puffs
Product|WASPE 60000 Launches in U.S. with 3-in-1 Design and 60,000 Puffs
The WASPE 60000 disposable vape has launched in the U.S. and Spain, priced at $6.45. Featuring a 3-in-1 design, it offers 60,000 puffs, 12 flavor combinations, and allows users to switch both flavors and nicotine strengths.
May.23 by 2FIRSTS.ai
BAT to Launch glo Hilo in Japan on June 9, Alongside Exclusive virto Sticks
BAT to Launch glo Hilo in Japan on June 9, Alongside Exclusive virto Sticks
BAT Japan has announced that its latest heated tobacco device, glo Hilo, will debut in Miyagi Prefecture on June 9, 2025, together with its dedicated virto sticks. Notably, Miyagi was also the launch site for the g
Jun.04 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai